Cargando…
Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology
Hepatocellular carcinoma (HCC) is a malignancy with a leading lethality. The etiology is quite diverse, ranging from viral infections to metabolic disorders or intoxications, and associates with specific somatic mutational patterns and specific host immunological phenotypes. Particularly, hepatitis...
Autores principales: | Huschka, Henriette, Mihm, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345952/ https://www.ncbi.nlm.nih.gov/pubmed/34360569 http://dx.doi.org/10.3390/ijms22157803 |
Ejemplares similares
-
Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data
por: Huschka, Henriette, et al.
Publicado: (2020) -
Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C
por: Amanzada, Ahmad, et al.
Publicado: (2015) -
COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
por: Mihm, Sabine
Publicado: (2020) -
Interferon-λ(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples
por: Amanzada, Ahmad, et al.
Publicado: (2013) -
Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk
por: Lee, Mei-Hsuan, et al.
Publicado: (2015)